General Information of the Compound
Compound ID
CP0515311
Compound Name
5-[4-[6-(3-ethoxyphenyl)-3-methyl-6-bicyclo[3.1.0]hexanyl]piperazin-1-yl]pyrimidine
    Show/Hide
Structure
Formula
C23H30N4O
Molecular Weight
378.52
Canonical SMILES
CCOc1cccc(c1)C1(C2CC(C)CC12)N1CCN(CC1)c1cncnc1
    Show/Hide
InChI
InChI=1S/C23H30N4O/c1-3-28-20-6-4-5-18(13-20)23(21-11-17(2)12-22(21)23)27-9-7-26(8-10-27)19-14-24-16-25-15-19/h4-6,13-17,21-22H,3,7-12H2,1-2H3
    Show/Hide
InChIKey
HJRJOUYNLRGGMJ-UHFFFAOYSA-N
Physicochemical Property
logP
3.5687
Rotatable Bonds
5
Heavy Atom Count
28
Polar Areas
41.49
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 73348990
ChEMBL ID
CHEMBL2397296
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000074 SK-N-MC Homo sapiens (Human)  1
1
IC50 = 5032 nM
   TI
   LI
   LO
   TS